Cipla Ltd - Share Price
CIPLA
Cipla LtdFinancials
Cipla LtdNews & Updates
Nifty Pharma trades flat as FDA nods Gileads remdesivir for Covid-19 treatment; Torrent Pharma, Cipl
Oct 23,2020 03:06 PM
Majority Indian listed pharma companies have the approval from Gilead to sell 'Remdesivir' under their respective brand name for C
Cipla launches generic Nintedanib for treatment of Idiopathic Pulmonary Fibrosis Oct 20,2020
Cipla launches Nintib to treat Idiopathic Pulmonary Fibrosis Oct 20,2020
Cipla allots 28,298 equity shares under ESOS Oct 15,2020
Nifty Pharma index underperforms; Lupin, Cipla stocks drag Oct 14,2020
Cipla to discuss results Oct 14,2020
Meeting Type
Meeting Date
| Resolution Type | Description Of Resolution | IiAS Recommendation |
|---|
Peer Comparison
| Name | LTP | PE | Mar Cap | NP Qtr | Div. Yld | Sales Qtr | BV |
|---|---|---|---|---|---|---|---|
| Sun Pharmaceuticals Industries Ltd | 484.50 | 39.00 | 116,211.79 | 531.95 | 0.83 | 2,878.64 | 101.68 |
| Dr Reddys Laboratories Ltd | 5,018.25 | 24.97 | 83,399.01 | 950.20 | 0.50 | 3,244.40 | 919.75 |
| Divis Laboratories Ltd | 3,068.85 | 50.97 | 81,425.85 | 492.25 | 0.52 | 1,709.96 | 275.61 |
| Cipla Ltd | 757.55 | 27.31 | 61,029.79 | 610.30 | 0.53 | 3,035.72 | 215.82 |
| Biocon Ltd | 417.20 | 146.90 | 50,064.00 | 95.00 | 0.00 | 560.00 | 64.73 |
Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in Cr.
Cipla LtdSummary & Reports
Cipla Ltd is one of the leading pharmaceutical companies in India. The company focuses on development of new formulations and has a wide range of pharmaceutical products. The product portfolio includes over 1,500 products across wide range of therapeutic categories.Cipla Ltd was incorporated in the year 1935 with the name Chemical, Industrial & Pharmaceutical Laboratories Ltd. Khwaja Abdul Hamied, the founder of Cipla gave the company ... More
Registered Office
Cipla House Peninsula Buss Par,Ganpatrao Kadam Mg Lower Parel,Mumbai, Maharashtra,400013
Tell. : +91-22-24826000
Website : http://www.cipla.com
Email : cosecretary@cipla.com
Registrar Office
Karvy Selenium Tow-B, Nanakramguda, Hyderabad-500032 INDIA
Tell. : +91-40-67162222
Website : www.kfintech.com
Email : einward.ris@kfintech.com
Reports by cipla-ltd
Latest Release by cipla-ltd
IIFLView
Buy - CIPLA
Reco. Price
513.00
Oct 25, 2020
Target Price
588.00
Target Returns:
14.62%
Result Express
Cipla Ltd's Q2FY19 consolidated net profit declines 10.8% yoy to Rs377.05cr: Misses Estimates
Oct 25, 2020 04:35 PM
The company’s consolidated revenue in the period stood at Rs4,011.9cr, down 1.73% yoy but up 1.85% qoq.
Shareholding Snapshot
Loading ...
| Sep - 2020 | |
|---|---|
| Promoter | - |
| Foreign | 21.69% |
| Indian | 14.95% |
| Total Promoter | 36.65% |
| Non Promoter | - |
| Institutions | 39.76% |
| Non-Institutions | 23.45% |
| Total Non-Promoter | 63.21% |
| Custodian | 0.15% |
| Total | 100% |
Corporate Action
Purpose
AGM
Exp. Date
27 Aug 2020
Annc. Date
03 Aug 2020
AGM 27/08/2020Please refer to our letter dated 3rd August, 2020 intimating the 84th Annual General M... More
Purpose
Board Meeting
Exp. Date
07 Aug 2020
Annc. Date
15 Jul 2020
CIPLA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on... More
Purpose
Board Meeting
Exp. Date
15 May 2020
Annc. Date
09 May 2020
CIPLA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on... More
